CCIA
EW icon

Campbell & Co Investment Adviser’s Edwards Lifesciences EW Stock Holding History

Campbell & Co Investment Adviser’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
+17,148
New +$1.44M 0.08% 397
2025
Q4 		– Sell
-14,409
Closed -$1.12M – 1210
2025
Q3 		$1.12M Sell
14,409
-6,336
-31% -$495K 0.08% 378
2025
Q2 		$1.62M Buy
+20,745
New +$1.55M 0.1% 304
2024
Q4 		– Sell
-3,084
Closed -$204K – 1138
2024
Q3 		$204K Buy
+3,084
New +$224K 0.02% 1014
2023
Q4 		– Sell
-3,434
Closed -$238K – 1168
2023
Q3 		$238K Sell
3,434
-415
-11% -$33.4K 0.03% 799
2023
Q2 		$363K Buy
+3,849
New +$335K 0.06% 580
2023
Q1 		– Sell
-3,205
Closed -$239K – 874
2022
Q4 		$239K Buy
+3,205
New +$247K 0.06% 627
2019
Q2 		– Sell
-8,589
Closed -$548K – 576
2019
Q1 		$548K Buy
+8,589
New +$490K 0.27% 93
2017
Q4 		– Sell
-30,291
Closed -$1.1M – 432
2017
Q3 		$1.1M Buy
+30,291
New +$1.16M 0.89% 9
2017
Q2 		– Sell
-10,950
Closed -$343K – 337
2017
Q1 		$343K Buy
+10,950
New +$343K 0.89% 38
2014
Q3 		– Sell
-22,164
Closed -$317K – 209
2014
Q2 		$317K Buy
+22,164
New +$300K 0.13% 139

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Campbell & Co Investment Adviser's EW Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Edwards Lifesciences (EW) in Q2 2026: 17,148 shares worth $1.55M. The stake represents 0.08% of the portfolio and ranks #397 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in EW as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in EW in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.62M in Q2 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Campbell & Co Investment Adviser held 17,148 shares of Edwards Lifesciences worth $1.55M as of Q2 2026.
  • Edwards Lifesciences was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Edwards Lifesciences made up 0.08% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #397 holding.
  • Campbell & Co Investment Adviser first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 11 quarters since.
  • Campbell & Co Investment Adviser's Edwards Lifesciences position peaked at $1.62M in Q2 2025.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.